NVO

NYSE · Healthcare

Novo Nordisk A/S

Q: Where is NVO trading today?

NVO last closed at $44.87, up 1.08% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $224.25 and a high of $533.40. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Q: What are analyst ratings for NVO stock?

Among 37 analysts covering NVO, the consensus rating is Hold — 12 rate it a buy, 23 hold, and 2 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Q: How much revenue does Novo Nordisk A/S generate?

Novo Nordisk A/S generated $2.12T in revenue during fiscal year 2026, with $701.58B reaching the bottom line as net income. The net profit margin of 33.1% is strong by most industry standards.

Q: What is the price-to-earnings ratio for NVO?

NVO trades at a P/E ratio of 11.16 on trailing earnings of $23.03 per share. That's below the S&P 500 average, suggesting the market may see limited growth or is pricing in sector-specific risks. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

Mega-Cap Stocks Blue Chip Stocks Best Dividend Stocks Highest Dividend Yield

$44.87

+0.48 (+1.08%)

As of May 5, 10:16 PM ET ·

Day Range $44.21 — $45.12

52W Range $224.25 — $533.40

Open$44.53

Previous Close$44.39

Day High$45.12

Day Low$44.21

52W High$533.40

52W Low$224.25

Volume—

Avg Volume5.93M

Market Cap1.14T

P/E Ratio11.16

EPS$23.03

SectorHealthcare

Analyst Ratings

Hold

37 analysts

12 Buy 23 Hold 2 Sell

Key Financials

	FY 2026	FY 2025
Revenue	2.12T	1.76T
Net Income	701.58B	524.30B
Profit Margin	33.1%	31.5%
EBITDA	1.02T	808.48B
Free Cash Flow	—	—
Rev Growth	+20.4%	+20.4%
Debt/Equity	0.67	0.67

Dividend

Dividend Yield4.55%

Annual Dividend$11.66

Payout Ratio50.5%

Frequencyquarterly

Ex-Dividend—

Pay Date—

Healthcare Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
AZN	AstraZeneca PLC	$181.65	-0.99%	30.5	230.48B
NVS	Novartis AG	$145.82	+0.83%	19.7	216.04B
RHHBY	Roche Holding AG	$50.28	-1.41%	—	—
SNY	Sanofi	$46.08	-1.07%	7.8	97.65B
GSK	GSK plc	$50.42	-0.16%	14.8	84.80B

NVO Frequently Asked Questions

Where is NVO trading today?

NVO last closed at $44.87, up 1.08% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $224.25 and a high of $533.40. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

What are analyst ratings for NVO stock?

Among 37 analysts covering NVO, the consensus rating is Hold — 12 rate it a buy, 23 hold, and 2 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

How much revenue does Novo Nordisk A/S generate?

Novo Nordisk A/S generated $2.12T in revenue during fiscal year 2026, with $701.58B reaching the bottom line as net income. The net profit margin of 33.1% is strong by most industry standards.

What is the price-to-earnings ratio for NVO?

NVO trades at a P/E ratio of 11.16 on trailing earnings of $23.03 per share. That's below the S&P 500 average, suggesting the market may see limited growth or is pricing in sector-specific risks. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.